27.03.2018

Cerenion granted funding for a 222,000€ project by the European Union

Cerenion Oy to receive significant funding from the European Regional Development Fund of the European Union.
The grant for a project of approximately 222,000€ has been awarded for the development of an ISO13485 -certified Quality Management System, and the related work in seeking the appropriate regulatory approvals and bringing the Cerenion C-Trend™ index to the international market. The non-dilutive funding will assist Cerenion in bringing its innovative brain monitoring technology to market in the European Union in the near future.
"We are grateful to the ERDF, the European Union and the Centre for Economic Development, Transport and the Environment in North Ostrobothnia for this grant. Aided by the grant we feel confident that we can bring our novel solution to the healthcare market in due time and really make a difference in the care of ICU patients.", says Dr. Timo Koskela, CEO of Cerenion.
Read more about the support .
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
OULU
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
FINLAND
HELSINKI
Cerenion Oy
Firdonkatu 2 T 63
00520 Helsinki
FINLAND
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2022 Cerenion Oy